Guides through decision to have a PSA test to check for prostate cancer. Includes what PSA results tell you and what they do not. Discusses who is at most risk for prostate cancer. Covers benefits and risks. Includes an interactive tool to help you decide.
Prostate Cancer Screening: Should I Have a PSA Test?
National Comprehensive Cancer Network (2013). Prostate cancer. NCCN Clinical Practice Guidelines in
Oncology, version 1.2013. Available online: http://www.nccn.org/professionals/physician_gls/
Chou R, et al. (2011). Screening for prostate cancer: A review of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 155(11): 762–771.
Djulbegovic M (2010). Screening for prostate cancer: Systematic review and meta-analysis of randomised controlled trials. BMJ, 341: c4543.
Hamilton AS, et al. (2001). Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the Prostate Cancer Outcomes Study. Journal of Clinical Oncology, 19(9): 2517–2526.
Hugosson J, et al. (2010). Mortality results from the Goteborg randomized population-based prostate-cancer screening trial. Lancet Oncology, 11(8): 725–732.
Ilic D, et al. (2011). Screening for prostate cancer: An updated Cochrane Systematic Review. British Journal of Urology International, 107(6): 882–891.
Schröder FH, et al. (2009). Screening and prostate-cancer mortality in a randomized European study. New England Journal of Medicine, 360(13): 1320–1328.
Talcott JA, et al. (2003). Time course and predictors of symptoms after primary prostate cancer therapy. Journal of Clinical Oncology, 21(21): 3979–3986.